Form 8-K - Current report:
SEC Accession No. 0000950170-24-001490
Filing Date
2024-01-04
Accepted
2024-01-04 07:17:50
Documents
16
Period of Report
2024-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20240104.htm   iXBRL 8-K 57516
2 EX-99.1 acet-ex99_1.htm EX-99.1 31537
3 EX-99.2 acet-ex99_2.htm EX-99.2 988
4 GRAPHIC img94724212_0.jpg GRAPHIC 2032
5 GRAPHIC acet-ex99_2s1.jpg GRAPHIC 302828
  Complete submission text file 0000950170-24-001490.txt   638465

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20240104.xsd EX-101.SCH 2472
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20240104_pre.xml EX-101.PRE 9902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20240104_lab.xml EX-101.LAB 13466
10 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240104_htm.xml XML 4755
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 24509757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)